For research use only. Not for therapeutic Use.
Sirtratumab Vedotin (ASG-15ME), is an antibody-drug conjugate (ADC) composed of SLTRK6 (SLIT and NTRK like family member 6, “SLIT and NTRK-like family, member 6”) and cytotoxic agent monomethyl auristatin E (MMAE). It delivers a small molecule microtubule-disrupting agent, monomethyl auristatin E (MMAE), to tumor cells expressing SLITRK6. SIRTRATUMAB VEDOTIN has the potential for Bladder Cancer, Metastatic urothelial cancer research.
| Catalog Number | I047466 |
| Purity | ≥95% |
| Reference | [1] Morrison K, et al. Mol Cancer Ther. 2016 Jun;15(6):1301-10. |
